Drug Type Small molecule drug |
Synonyms macromolecular carrier-linked carbon monoxide releasing molecules (Alfama), ALF-421 |
Target |
Action inhibitors |
Mechanism TNF inhibitors(Tumor necrosis factor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Liver Failure, Acute | Preclinical | United States | - | |
| Metabolic Dysfunction Associated Steatohepatitis | Preclinical | United States | - | |
| Neoplasms | Preclinical | United States | - | |
| Ileus | Discovery | United States | - | |
| Inflammation | Discovery | Portugal | - |





